retatrutide clinical trial results 2025 Lilly orforglipron oral GLP-1 phase 3 weight loss Retatrutide Helped Adults With Obesity

veterans showed a 28% lower risk of kidney problems in those using GLP-1 agonists compared to other diabetes drugs

Studies show that GLP-1RAs enhance insulin production, motility, and sperm metabolism, all of which can result in improved sperm parameters

Retatrutide continues producing weight loss beyond the 24-week mark, suggesting that appetite-related effects also continue deepening or at minimum remain stable

However, stopping the medication also means losing the appetite suppression and weight loss benefits

Will Anthem cover Mounjaro if I also have type 2 diabetes

Brain activation in response to low-calorie food pictures: an explorative analysis of a randomized trial with dapagliflozin and exenatide